EUVIMEDEUVIMED entdecken
Crossref

Local Control and Outcomes Associated With Proton Spine Hypofractionated Radiation Therapy

Christopher B Jackson, Daniel S Higginson, Haibo Lin, Dennis Mah, Justin Haseltine, Boris A Mueller, Adam M Schmitt, Max Vaynrub, William Christopher Newman, Rabih Bou-Nassif, Eric Lis, Ori Barzilai und 2 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-11 · 126 (4) · 996-1003

DOI: 10.1016/j.ijrobp.2026.08.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-11. Verfasst von Christopher B Jackson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: jacksoc2@mskcc.org. Hauptthemen laut MEDLINE: Proton Therapy, Radiation Dose Hypofractionation, Spinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Little is known about the long-term outcomes of patients with spinal metastases treated with proton hypofractionated radiation therapy (RT), particularly in the setting of re-irradiation (re-RT). METHODS AND MATERIALS: This is a retrospective cohort study of patients treated between 2015 and 2023 using proton hypofractionated RT (≤10 fractions). All patients received follow-up magnetic resonance imaging at least 1 month after treatment. Outcomes of interest included local failure, defined radiographically, and long-term adverse events. RESULTS: A total of 52 patients treated for 58 lesions met the inclusion criteria. Median follow-up after RT was 14 months (IQR, 8-25). The most common dose-fractionation scheme was 40 Gy in 5 fractions (n = 47; 81%). There were 10 cases of first-time RT using protons (17%), whereas 25 courses (43%) were second-time re-RT, 19 courses (33%) were third-time re-RT, and 4 courses (6.9%) were fourth-time re-RT. Median cumulative equivalent dose in 2-Gy fractions was 115 Gy (IQR, 91-153). The 1-year local failure rate was 10% (95% CI, 4%-20%), and the 2-year local failure rate was 22% (95% CI, 12%-35%). There were 5 grade (G) 3 adverse events, including radiation myelitis (1), esophageal fistula (1), esophageal stricture (1), wound dehiscence (1), and bowel necrosis (1). All G3 adverse events occurred in patients who received 3-4 overlapping courses of RT. There were no G4-5 adverse events. CONCLUSIONS: Proton hypofractionated RT is associated with excellent local control in this large cohort of heavily re-irradiated patients (81% re-RT). G3 adverse events were limited to patients who received 3-4 overlapping courses of RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyRadiation Dose HypofractionationSpinal NeoplasmsHumansRetrospective StudiesRe-IrradiationFemaleMaleMiddle AgedAgedMagnetic Resonance ImagingTreatment OutcomeFollow-Up Studies

Autor:innen und Institutionen

  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: jacksoc2@mskcc.org.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Physics, New York Proton Center, New York, New York.
  • Department of Physics, ProCure, Sommerset, New Jersey.
  • Department of Orthopedic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Förderung

  • National Institutes of Health

Zitieren

APA

Jackson, C. B., Higginson, D. S., Lin, H., Mah, D., Haseltine, J., Mueller, B. A., Schmitt, A. M., Vaynrub, M., Newman, W. C., Bou-Nassif, R., Lis, E., Barzilai, O., Bilsky, M. H., & Yamada, Y. (2026). Local Control and Outcomes Associated With Proton Spine Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics, 126(4), 996-1003. https://doi.org/10.1016/j.ijrobp.2026.08.003

Vancouver

Jackson CB, Higginson DS, Lin H, Mah D, Haseltine J, Mueller BA, et al. Local Control and Outcomes Associated With Proton Spine Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(4):996-1003. doi:10.1016/j.ijrobp.2026.08.003

BibTeX
@article{Jackson2026,
  author = {Jackson, Christopher B and Higginson, Daniel S and Lin, Haibo and Mah, Dennis and Haseltine, Justin and Mueller, Boris A and Schmitt, Adam M and Vaynrub, Max and Newman, William Christopher and Bou-Nassif, Rabih and Lis, Eric and Barzilai, Ori and Bilsky, Mark H and Yamada, Yoshiya},
  title = {Local Control and Outcomes Associated With Proton Spine Hypofractionated Radiation Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {4},
  pages = {996--1003},
  doi = {10.1016/j.ijrobp.2026.08.003}
}
Kostenlos starten →